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Abstract: Preoperative malnutrition and weight loss negatively impact postoperative outcomes in
various surgical fields. However, for gynecologic surgery, evidence is still scarce, especially if surgery
is performed within enhanced recovery after surgery (ERAS) pathways. This study aimed to assess
the prevalence and impact of preoperative weight loss in patients undergoing major gynecologic
procedures within a standardized ERAS pathway between October 2013 and January 2017. Out of
339 consecutive patients, 33 (10%) presented significant unintentional preoperative weight loss of
more than 5% during the 6 months preceding surgery. These patients were less compliant to the
ERAS protocol (>70% of all items: 70% vs. 94%, p < 0.001) presented more postoperative overall
complications (15/33 (45%) vs. 69/306 (22.5%), p = 0.009), and had an increased length of hospital
stay (5 ± 4 days vs. 3 ± 2 days, p = 0.011). While patients experiencing weight loss underwent
more extensive surgical procedures, after multivariate analysis, weight loss ≥5% was retained as
an independent risk factor for postoperative complications (OR 2.44; 95% CI 1.00–5.95), and after
considering several surrogates for extensive surgery including significant blood loss (OR 2.23; 95% CI
1.15–4.31) as confounders. The results of this study suggest that systematic nutritional screening in
ERAS pathways should be implemented.
Keywords: enhanced recovery; weight loss; nutrition; surgery; gynecologic/oncology; gynecology;
prehabilitation
1. Introduction
Preoperative conditioning, recognized as an efficient way to improve surgical outcomes, has been
of growing interest in the last decades and endorsed by nutritional societies and perioperative care
guidelines [1,2]. Nutritional support strategies have been evaluated and validated for different surgical
specialties, including colorectal [3], hepatic [4], or gastric [5] surgery, and for more specific settings,
such as surgery for Crohn’s disease [6].
However, in gynecological surgery, evidence is scarce. While specific enhanced recovery after
surgery (ERAS) guidelines incorporate multimodal interventions aiming to improve patients’ physical
and mental well-being [7], the nutritional aspect focuses on the immediate perioperative period,
suggesting limited preoperative fasting, carbohydrate repletion, and early postoperative re-alimentation.
However, systematic screening and support strategies for malnourished patients are not specifically
recommended. Despite implementation of ERAS guidelines in the gynecological department in 2012,
nutritional screening and therapy are not an integral part of daily clinical practice at the present
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institution. This study thus aimed to assess the prevalence and clinical consequences of preoperative
weight loss among patients treated within the standardized ERAS pathway.
2. Materials and Methods
2.1. Patients
This retrospective study was conducted at Lausanne University Hospital (CHUV), Switzerland,
in the gynecologic oncology unit. The study protocol was approved by the local review board
(CER-VD # 2017-01996) and was considered as a quality improvement project. Therefore, no written
informed consent was requested by the local review board to conduct the study. Results were
reported in accordance to the STROBE (Strengthening the Reporting of Observational Studies in
Epidemiology) statement.
All consecutive women undergoing elective major (>2 h, general anesthesia, ovarian, uterine,
pelvic/lombo-aortic lymphadenectomy, peritonectomy, small-large bowel resection) gynecologic
surgery within an ERAS program between October 2013 and January 2017 were included. Patients’
demographics, surgical details, postoperative complications, and length of hospital stay were prospectively
recorded by a dedicated clinical nurse. Demographic items (Table 1) included age, American Society of
Anesthesiologists (ASA) group, body mass index (BMI), smoking status, diabetes, immunosuppressants
usage (i.e., any medication other than chemotherapy causing significant immunosuppression within
two weeks prior to surgery (i.e., systemic steroid therapy and specific immunosuppressants, but not
non-steroidal anti-inflammatory drugs (NSAIDs) or low dose steroids <10 mg)), length of hospital stay,
surgical approach (i.e., minimally invasive versus open surgery), debulking procedure, and duration
of procedure. Impact of every individual ERAS item and of overall compliance to ERAS items of
>70% were assessed. Surgical complexity scores were modified, according to the original score from
Aletti et al. (i.e., ponderation of 12 procedures with individual weighting (max 18 points), allowing
gradation for surgical complexity in two groups (low: ≤3 versus high: ≥4)) (Table S1). Cutoffs for
continuous variables were set according to institutional standards and ERAS guidelines [8,9].
Table 1. Demographics and surgical details.
All Patients
(n = 339)
Weight Loss ≥5%
(n = 33)
Weight Loss <5%
(n = 306) p
Age (years; mean ± SD) 51 ± 12 53 ± 14 51 ± 12 0.491
>70 years (%) 31 (9) 4 (12) 27 (9) 0.524
ASA group (III–IV; %) 23 (7) 3 (9) 20 (7) 0.481
BMI (kg/m2; mean ± SD) 26 ± 6 26 ± 7 26 ± 6 0.798
>25 kg/m2 174 (51) 13 (39) 161 (53) 0.149
Weight at surgery (kg; mean ± SD) 70 ± 15 69 ± 17 70 ± 15 0.790
6 months preoperatively
Weight loss over 6 months (kg; mean ± SD)
70 ± 15
−0.4 ± 3
76 ± 18
−7 ± 4
70 ± 15
0 ± 2
0.070
<0.001
Smoker (%) 64 (19) 4 (12) 60 (20) 0.358
Diabetes (%)
Malignancy (%)
16 (5)
132 (39)
0
22 (67)
16 (5)
110 (36)
0.383
0.001
Immunosuppression (%) 12 (4) 5 (15) 7 (2) 0.003
Minimal invasive approach (%) 244 (72) 17 (52) 227 (74) 0.008
Debulking procedure (%) 37 (8) 9 (27) 16 (5) <0.001
Duration of operation (min; mean ± SD) 180 ± 80 240 ± 90 180 ± 80 0.001
>180 min 137 (40) 23 (70) 114 (37) 0.001
Modified Aletti score (>3; %) 24 (7) 7 (21) 17 (6) 0.005
Intraoperative blood loss (mL; mean ± SD) 270 ± 260 320 ± 270 270 ± 260 0.352
>200 mL 192 (57) 20 (61) 172 (56) 0.628
Baseline demographic parameters of patients with (n = 33) and without (n = 306) preoperative weight loss ≥5%
within 6 months before surgery. BMI: Body Mass Index; ASA: American Society of Anesthesiologists; SD: Standard
deviation. Age, BMI, duration of operation, and intraoperative blood loss are presented as means ± standard
deviation. All others are frequencies and percentages. A bold p-value indicates statistical significance (p < 0.05).
ERAS items for compliance calculation (Figure 1 are divided into three main groups, as previously
described [10]; pre-operative: preadmission patient education, preoperative oral carbohydrate
treatment, oral bowel preparation, preoperative long-acting sedative medication, antibiotic prophylaxis
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before incision, thrombosis prophylaxis; intra-operative: postoperative nausea and vomiting (PONV)
prophylaxis, epidural if debulking, upper-body forced-air heating cover, total IV volume of fluids
intraoperatively with a cut off of 200 mL, fluid administration guidance; and post-operative: nasogastric
tube used postoperatively, resection-site drainage, stimulation of gut motility postoperatively, oral
nutritional supplements taken on day of surgery with a cut off of 300 kcal, amount of oral fluids taken
postoperatively on day of surgery with a cut off of 800 mL, mobilization at all postoperatively on day
of surgery, the time to termination of urinary drainage with a cut off of less than 48 h after surgery, and
the time to termination of IV fluid infusion with a cut off of less than 48 h after surgery. Compliance
with individual ERAS care items and overall ERAS compliance, using a cutoff of 70%, were assessed
for each patient [10,11].
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Significant weight loss was defined as unintentional loss of more than 5% during the 6 months 
prior to surgery [13]. 
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Figure 1. Comparison of compliance to pre-, intra-, and postoperative ERAS items of patients with
preoperative weight loss ≥5% within 6 months of surgery (n = 33, black bars) and patients with
<5% weight loss (n = 306, grey bars). ERAS: enhanced recovery after surgery; PONV: postoperative
nausea and vomiting prophylaxis; EDA: epidural anesthesia; ONS: postoperative oral nutritional
supplements; POD: postoperative day; IV: intravenous. * indicates statistical significance (p < 0.05).
NGT: Nasogastric tube.
A modified surgical complexity score was used to assess the extent of surgery, according to the
original score from Aletti et al., (i.e., ponderation of 12 procedures with individual weighting, max.
18 points), allowing gradation for surgical complexity in two groups (low: ≤3 vs. high: ≥4) (Table S1) [12].
2.2. Assessment of Weight and Definition of Significant Weight Loss
Weight 6 months prior to surgery was either patient-reported or recorded as per primary care
physician. Preoperative body weight was systematically assessed within 2 weeks of surgery during
preoperative outpatient visits.
Significant weight loss was defined as unintentional loss of more than 5% during the 6 months
prior to surgery [13].
2.3. Outcomes
The main outcome was defined as overall postoperative complications, assessed in-hospital and
within 30 postoperative days (outpatient control visit) [14]. The secondary outcome was defined as
length of hospital stay.
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2.4. Statistical Analysis
Comparative univariate analysis of patients with ≥5% vs. <5% weight loss was performed with
chi-squared test (categorical variables) and t-test (continuous variables). Adherence to modifiable
ERAS items was calculated in order to assess compliance to individual ERAS items according to
previous methodology [10]. In a second step, univariate risk factors (p < 0.05) for overall complications
were retained to provide adjusted estimations of the odds ratio (OR) through multinominal logistic
regression analysis. Data analysis was performed with the Statistical Software for the Social Sciences
SPSS Advanced Statistics 22 (IBM Software Group, Chicago, IL, USA).
3. Results
3.1. Patients
Out of 339 patients, 33 (10%) presented with significant preoperative weight loss of at least 5%.,
while 14 (42%) of these patients presented a weight loss >10%. On average, these patients lost 7 ± 4 kg
of their initial body weight. Demographic and surgical details of both groups (≥5% vs. <5% weight
loss) are displayed in Table 1.
While the demographic characteristics of both groups were similar, they differed significantly
regarding several surrogates for extensive surgery, including open approach, debulking procedure,
duration of operation >180 min, modified Aletti score >3, and intraoperative blood loss >200 mL.
3.2. Outcome
Patients with significant weight loss experienced more overall complications (15/33 (45%) vs.
69/306 (22.5%), p = 0.009) and a longer length of stay (5 ± 4 days vs. 3 ± 2 days, p = 0.011), as
illustrated in Figure 2. Overall, surgery-related complications (including intra-operative complications,
wound complications, postoperative ileus, and pain) occurred in 41 patients (49%), whereas medical
complications occurred in 43 patients (51%), with medical infectious complications in 21 patients (25%).
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Figure 2. Comparison of postoperative morbidity and length of hospital stay in patients with
preoperative weight loss ≥5% within 6 months of surgery (n = 33, black bars) and patients with <5%
weight loss (n = 306, grey bars). Asterisk (*) indicates statistical significance (p < 0.05).
3.3. ERAS Compliance
Compliance to pre-, intra-, and postoperative ERAS items is displayed in Figure 1. Significant
differences between the two groups (≥5% vs. <5% weight loss) were found for intraoperative fluid
administration <2 L (61% vs. 84%, p = 0.003), fluid guidance (31% vs. 10%, p = 0.002), avoidance of
prophylactic nasogastric tubes (NGTs) postoperatively (82% vs. 98%, p < 0.001), mobilization at all on
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postoperative day (POD) 0 (63% vs. 81%, p = 0.029), removal of urinary Foley catheter within 48 h
(55% vs. 84%, p < 0.001), IV fluid termination within 48 h (62% vs. 91%, p < 0.001), and overall ERAS
compliance >70% (70% vs. 94%, p < 0.001).
3.4. Risk Factors for Postoperative Complications
Multivariable analysis retained significant blood loss >200 mL (OR 2.23; 95% CI 1.15–4.31,
p = 0.017) and significant weight loss ≥5% (OR 2.44; 95% CI 1.00–5.95, p = 0.05) as independent risk
factors for postoperative complications (Figure 3).
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95% confidence intervals (black lines). Significant associations (p < 0.05) are represented in bold. ERAS:
enhanced recovery after surgery.
4. Discussion
This study revealed significant preoperative weight loss of >5% in 10% of consecutive unselected
patients undergoing a major gynecologic procedure. Furthermore, significant weight loss adversely
affected ERAS compliance and length of stay and had a negative impact on the postoperative course,
with a 2.5-fold increased risk of adverse events upon multivariable analysis, which considered several
surrogates of surgical complexity as confounders.
Malnutrition is a heavy burden for the hospitalized patient, the hospital, and the community
and has been comprehensively documented, with a prevalence of up to 73.2% [15]. Similar rates
of up to 66% have been described in surgical patients [16], while 20–53% of patients suffering from
gynecological cancer present with at least mild malnutrition at diagnosis [17,18]. ERAS protocols
in gynecologic surgery aim to improve perioperative nutritional status by focusing on short pre-
and postoperative fasting periods and by counterbalancing perioperative insulin resistance [19].
However, the 10% incidence of significant weight loss revealed by the present study calls for the
active identification and management of malnourished patients before hospital admission. At a first
glance, the observed rate lies within the lower portion of reported ranges. However, no comparative
studies focusing on preoperative weight loss within an ERAS setting are available in the gynecologic
field. Despite improvements in perioperative care, the present findings support implementation of
systematic nutritional screening and, for patients at risk, conditioning through tailored nutritional
interventions. This is even more important considering the independent adverse impact of weight loss
on postoperative outcomes and duration of hospital stay. Even though not specifically assessed by
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the present study, further clinical consequences of preoperative weight loss may include an increased
risk of surgical site infections [20], lower quality of life (QoL) scores [21], and a significant increase in
hospital costs [22,23].
The present study assessed malnutrition solely through significant weight loss. Validated screening
tools were not systematically used, which may have led to an underestimation of the actual prevalence
of malnutrition in the present cohort. In particular, preoperative food intake was not specifically
assessed. Screening with the widespread, and easy to use, nutritional risk score (NRS-2002) could
be performed [24]. After identification of patients at risk, more detailed assessment by nutritional
specialists may help to define tailored nutritional support strategies [25]. However, a multitude of
different screening tools are available and should be used according to institutional standards and
local preferences [1].
Type and timing of nutritional support strategies are still a matter of debate [17]. Immunonutrition
(combination of amino acids, polyunsaturated fatty acids, and nucleotides or RNA) was recently.
No significant difference was found in terms of morbidity at 90 days or survival, but length of stay
was shorter in supplemented patients [26]. A prior review evaluating immunonutrition in major
abdominal surgery showed reduced mortality, morbidity, and length of hospital stay [27]. A small
group of gynecological patients benefited from immunonutrition perioperatively, with a trend toward
decreased complications and length of stay (LOS) [24].
Considering recent achievements in perioperative care, the nutritional aspect may be neglected in
gynecology, despite encouraging studies [28,29]. In the ERAS guidelines for gynecologic surgery [8,9],
there is a real absence of consideration of weight variation. Furthermore, the recently updated
guidelines [30], despite recognizing malnutrition as important, do not recommend integrating a
prehabilitation program in gynecology. The main reasons for this decision are the heterogeneity of
cited studies, varying endpoints, and, most importantly, the lack of large-scale studies in gynecology
with consequent extrapolation of results from digestive studies. Just as it has been unattended by the
guidelines, the nutritional component of care may have been neglected in our cohort.
There are limitations to this study beyond its retrospective setting. The study cohort is
heterogeneous due to the inclusion of consecutive unselected patients. This was accounted for
through stratification of surgical complexity. However, both groups differed with regard to extent of
surgery, surgical indication, and demographic characteristics. This was addressed by multinominal
logistic regression considering all surrogates of surgical extent as confounders and including all
univariate risk factors for postoperative complications. Despite standardized care, results of the present
single-center study may not be uncritically extrapolated to other settings. Socio-economic factors that
may potentially impact the results were not available in the dataset. No formal nutritional screening
was performed in the setting of this study, which may have led to an underestimation of malnutrition.
Anthropometric measurements to assess, for instance, catabolic state through lean body mass or muscle
mass were not performed either. This should be addressed through formal screening by nutritional
specialists in future studies.
5. Conclusions
In conclusion, preoperative weight loss was identified as an independent risk factor for
postoperative complications. Systematic nutritional screening and treatment of malnourished patients
before hospital admission should be proposed for gynecologic patients treated within an enhanced
recovery pathway.
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